Prohibits sale of products containing 7-hydroxymitragynine above specified levels; sets fines for violations.
New York S08925 amends the general business law to prohibit the sale of products containing 7-hydroxymitragynine at levels exceeding 2% of total alkaloids or one milligram per serving. The bill imposes civil penalties on businesses found in violation, with fines up to $500 for a first offense and $1,000 for subsequent violations. Funds collected from these penalties will be deposited into the New York state drug treatment and public education fund.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.